Bristol-Myers Squibb is the first major drug firm to forgo advertising new drugs to consumers in a product’s first year on the market
I applaud the move. Not quite a ban on DTC advertising, but it’s a start.
Bristol-Myers Squibb is the first major drug firm to forgo advertising new drugs to consumers in a product’s first year on the market
Real physician voices, twice a week
Free, and one click to unsubscribe.

